Perceptive Advisors’s Day One Biopharmaceuticals DAWN Stock Holding History

Perceptive Advisors’s Portfolio DAWN Stock Details DAWN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,755,799	Closed	-$37.6M	–	113
2026 Q1	$37.6M	Buy	+1,755,799	New	+$24.7M	0.74%	33
2022 Q3	–	Sell	-556,047	Closed	-$9.95M	–	118
2022 Q2	$9.95M	Hold	556,047	–	–	0.31%	60
2022 Q1	$5.52M	Hold	556,047	–	–	0.11%	101
2021 Q4	$9.37M	Hold	556,047	–	–	0.14%	99
2021 Q3	$13.2M	Sell	556,047 -200,000	-26%	-$4.79M	0.19%	88
2021 Q2	$17.2M	Buy	+756,047	New	+$15.8M	0.22%	86

Other funds holding DAWN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Perceptive Advisors's DAWN Position: Q2 2026 in Review

Perceptive Advisors sold out of Day One Biopharmaceuticals (DAWN) in Q2 2026, closing a stake of 1,755,799 shares — an estimated $37.6M sold.

Perceptive Advisors first reported a position in DAWN in Q2 2021 and held it in 6 quarters. The position peaked at $37.6M in Q1 2026. 1 fund tracked by Wall St. Rank holds DAWN as of Q2 2026.

Perceptive Advisors reported no remaining Day One Biopharmaceuticals position as of Q2 2026 after selling out during the quarter.
Perceptive Advisors sold 1,755,799 Day One Biopharmaceuticals shares in Q2 2026, an estimated $37.6M.
Perceptive Advisors first reported a position in Day One Biopharmaceuticals in Q2 2021 and held it in 6 quarters.
Perceptive Advisors's Day One Biopharmaceuticals position peaked at $37.6M in Q1 2026.
1 fund tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2026.

Based on Perceptive Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.